Willemijn Hobo

PD-1 Blockade Augments Th1 and Th17 and Suppresses Th2 Responses in Peripheral Blood From Patients With Prostate and Advanced Melanoma Cancer

John Dulos, Gregory J. Carven, Susan J. van Boxtel et al. · Journal of Immunotherapy · 2012 · 318 citations

Life Sciences, Immunology, Oncology +17

Noninvasive Imaging of Tumor PD-L1 Expression Using Radiolabeled Anti–PD-L1 Antibodies

Sandra Heskamp, Willemijn Hobo, Janneke D.M. Molkenboer‐Kuenen et al. · Cancer Research · 2015 · 238 citations

Medicine, Nuclear Medicine, Oncology +17

PD-1/PD-L1 Interactions Contribute to Functional T-Cell Impairment in Patients Who Relapse with Cancer After Allogeneic Stem Cell Transplantation

Wieger J. Norde, Frans Maas, Willemijn Hobo et al. · Cancer Research · 2011 · 173 citations · Full text

Life Sciences, Immunology, Oncology +17

siRNA silencing of PD-L1 and PD-L2 on dendritic cells augments expansion and function of minor histocompatibility antigen–specific CD8+ T cells

Willemijn Hobo, Frans Maas, Niken Adisty et al. · Blood · 2010 · 153 citations · Full text

Life Sciences, Immunology, Molecular Genetics +14

Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporation

Willemijn Hobo, Tatiana I. Novobrantseva, Hanny Fredrix et al. · Cancer Immunology Immunotherapy · 2012 · 124 citations · Full text

Life Sciences, Immunology, Pharmaceutical Biotechnology +17